drugset / Trial / NCT01096186
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the long term safety and clinical utility of IPX066 in subjects with Parkinson's Disease.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IPX066 | Unknown | 95 mg | — |
| Subject | IPX066 | Unknown | 145 mg | — |
| Subject | IPX066 | Unknown | 195 mg | — |
| Subject | IPX066 | Unknown | 245 mg | — |